HKEX
Beyond's analysis on HKEX
- — Insilico Medicine’s inclusion in the HKEX Tech 100 Index highlights rising investor interest in AI‑powered drug discovery
- — Insilico Medicine schedules 2026 interim earnings call, signaling transparency ahead of clinical milestones in AI-driven drug discovery
Recent news mentioning HKEX
- — Insilico Medicine Included in the HKEX Tech 100 Index, Drawing Attention to Opportunities in AI Value Chain
- — HKEX Launches 5-Year China Government Bond Futures